Precision Scientific and Illumina reach astrategic cooperation to focus on the registration of tumor associated diagnostic products

普瑞基准与因美纳（Illumina）公司达成战略合作协议并成为IVD合作伙伴，双方将在肿瘤伴随诊断产品注册方面开展深入合作，全力推进肿瘤伴随诊断检测试剂盒在中国地区的注册和应用。此次合作，将结合双方技术优势，采用Illumina MiSeqDx测序平台开发基于NGS方法的胰腺癌伴随诊断试剂，促进NGS技术和伴随诊断产业在临床领域的发展和应用。

近年来，二代测序技术发展速度飞快并为精准医疗的快速发展贡献了巨大力量。普瑞基准与Illumina 公司的合作，意味着全球领先的测序技术和卓越的转化医学研究能力强强联合，为临床和药企提供最先进的伴随诊断解决方案。

Precision Scientific has reached a strategic cooperation agreement with Illumina and became IVD partner, in which both sides will carry out in-depth cooperation in the registration of cancer companion diagnostic products, and try the best to promote the registration and application of cancer companion diagnostic kits in China. This cooperation will combine the technological advantages of both, and utilize Illumina MiSeqDx sequencing platform to develop pancreatic cancer companion diagnostic reagent based on NGS, so as to promote the development and application of NGS technology and companion diagnostic industry in the clinical field.

In recent years, next generation sequencing has developed rapidly and contributed a lot to the rapid development of precision medicine. The partnership between Illumina and Precision Scientific represents a combination of world-leading sequencing technology and excellent translational medicine research ability to provide the most advanced companion diagnostic solutions for clinicians and pharmaceutical companies.

关于普瑞基准

普瑞基准科技（北京）有限公司是一家“多组学+数据挖掘”驱动的新型转化医学公司，聚焦肿瘤精准诊疗。公司以先进的多组学技术、生物信息学分析为基础，以数据挖掘为核心竞争力，助力于肿瘤精准医疗的实现。公司为医药企业提供转化医学服务、中心实验室服务以及伴随诊断产品开发等“组学+生物信息学”相关内容的一站式服务，已与多家国内外领先的药企形成深度合作。同时，公司也为医生与患者提供先进、精准的检测服务，助力临床精准医疗的实践。

Precision Scientific (Beijing) CO., LTD. is a national high-tech enterprise focusing on accurate diagnosis and treatment of tumor. Based on advanced multi omics technology and bioinformatics analysis, the company takes data mining as its core competitiveness, and contributes to the realization of tumor precision medicine. The company provides pharmaceutical enterprises with one-stop services related to "omics + bioinformatics", including translational medicine services, central laboratory services and accompanying diagnostic product development. The company has established deep cooperation with numbers of world-leading pharmaceutical companies. At the same time, the company also provides advanced and accurate testing services for doctors and patients to help the practice of clinical precision medicine.

关于因美纳（Illumina）

因美纳公司致力于推动和激发基因组学的发展而不断改善人类健康。专注创新使我们成为全球基因测序和芯片技术的领导者，并为全球范围的科研、临床和应用市场客户提供专业服务。我们的产品广泛应用于生命科学、肿瘤学、生殖保健、农业及其他新兴领域。欲了解更多信息，请访问www.illumina.com.cn或关注因美纳微信公众号。

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram, and YouTube.

阿斯利康 & 普瑞基准 达成卵巢癌伴随诊断战略合作

普瑞基准科技与百图生科达成战略合作，共同构建生物计算生态，赋能肿瘤多组学研究

普瑞基准与艾德摩达成战略合作，打造新药研究转化医学新模式

新动作：恒瑞医药与普瑞基准签署战略合作协议！普瑞基准是谁？